Home - MedCramChina

新冠（COVID-19）疫情

瑞德西韦的定价与药品供应中的差异（新冠讲座91）

2 months ago

Update 91: Remdesivir Pricing & Disparities in Drug Availability 本文由‘中国推动’学者、济南大学生命科学学院生物技术专业任紫豪同学编辑整理。 Welcome to another MedCram COVID-19...

Video

新冠（COVID-19）疫情

使用经过验证的工具评估COVID-19信息的质量(新冠讲座90)

2 months ago

MedCramChina

Update 90: Assess the Quality of COVID-19 Info with a Validated Tool 本文由‘中国推动’学者、江南大学药学院石漱新同学编辑整理。 MedCram.com. Welcome to another MedCram COVID-19...

Video

新冠（COVID-19）疫情

Infection Rate Rising in Many States; Dexamethasone Cautions

3 months ago

MedCramChina

Update 89: Infection Rate Rising in Many States; Dexamethasone Cautions Medcram.com wasn’t another medcram covid-19 updates here. We can see...

Video

新冠（COVID-19）疫情

Dexamethasone History & Mortality Benefit Data Released from UK Trial

3 months ago

MedCramChina

Update 88: Dexamethasone History & Mortality Benefit Data Released from UK Trial Medcram.com welcome to another medcram covid-19 updates. So in...

Video

新冠（COVID-19）疫情

More on Dexamethasone; Do COVID-19 antibodies last?

3 months ago

MedCramChina

Update 87: More on Dexamethasone; Do COVID-19 antibodies last? 本文由‘中国推动’学者、江南大学药学院石漱新同学编辑整理。 MedCram.com. Welcome to another MedCram COVID-19 update...

Video

新冠（COVID-19）疫情

COVID-19 Testing and Cases Increasing but Daily Deaths Decreasing

3 months ago

MedCramChina

Update 86: COVID-19 Testing and Cases Increasing but Daily Deaths Decreasing 本文由‘中国推动’学者、济南大学生命科学学院生物技术专业任紫豪同学编辑整理。 Welcome to another MedCram COVID...

Acute Kidney Injury: Introduction with BUN and Creatinine and the Nephron

负压通气、正压通气、PEEP原理及注意事项

CBTI 及CBTI和安眠药(Zolpidem)混合治疗失眠（失眠讲座6）

安眠药适用范围、副作用等（失眠讲座5）

干扰素Beta COVID-19治疗和回顾性研究（新冠讲座100）

Long Haulers-COVID-19之后的长期症状和长期症状（新冠讲座99）

维生素D和COVID-19免疫力，内皮细胞和缺乏症(新冠讲座97)

RNA疫苗；伊维菌素;冯·威兰布兰德因子和COVID-19

尸检的广泛血栓形成；预后因素[新冠讲座95]

吸入类固醇的COVID-19治疗(新冠讲座94)

COVID-19的抗体，免疫性和流行度-西班牙的新数据(新冠讲座93)

COVID-19和血凝块-新内皮和自由基研究(新冠讲座92)

瑞德西韦的定价与药品供应中的差异（新冠讲座91）

使用经过验证的工具评估COVID-19信息的质量(新冠讲座90)

Infection Rate Rising in Many States; Dexamethasone Cautions

Dexamethasone History & Mortality Benefit Data Released from UK Trial

More on Dexamethasone; Do COVID-19 antibodies last?

COVID-19 Testing and Cases Increasing but Daily Deaths Decreasing

地塞米松和新冠病人在医院要问的关键问题（新冠讲座85）

感染新冠要在医院问的关键问题（新冠讲座84）

高果糖，维生素D和氧化应激(新冠讲座83)

COVID-19和维生素D的种族差异(新冠讲座82)

羟氯喹副作用的新数据及COVID-19的预防(新冠讲座81)

数据问题和期刊撤稿(新冠讲座80)

五种疫苗值得关注(新冠讲座79)

口罩争议； COVID-19的疫苗更新(新冠讲座78)

新冠知识与Seheult医生的现场问答

瑞德西韦更新；墨西哥的COVID-19(新冠讲座77)

抗体检测COVID-19中的假阳性 (新冠讲座76)

肝脏疾病明确解释-胆汁淤积性疾病 (讲座4)

最新视频

瑞德西韦的定价与药品供应中的差异（新冠讲座91）

使用经过验证的工具评估COVID-19信息的质量(新冠讲座90)

Infection Rate Rising in Many States; Dexamethasone Cautions

Dexamethasone History & Mortality Benefit Data Released from UK Trial

More on Dexamethasone; Do COVID-19 antibodies last?

COVID-19 Testing and Cases Increasing but Daily Deaths Decreasing